Journal of Cellular Physiology, ISSN 0021-9541, 02/2019, Volume 234, Issue 2, pp. 1768 - 1779
Despite different molecular tumor profiles indicate that human epidermal growth factor receptor 2 (HER2) messenger RNA (mRNA) levels mirror HER2 addiction and...
oncogene addiction | breast cancer | HER2 | lactate | glycolysis | ADJUVANT CHEMOTHERAPY | MULTICENTER | PHYSIOLOGY | TRASTUZUMAB | EFFICACY | OPEN-LABEL | HYPOXIA | CELL BIOLOGY | GROWTH | TREATMENT RESPONSE | EXPRESSION | PLUS | Lactates | Breast cancer | DNA microarrays | Analysis | Enrichment | Biotechnology | Nuclear magnetic resonance--NMR | Transcription | Transgenic | Metabolism | Gene expression | Addictions | Ribonucleic acid--RNA | ErbB-2 protein | Magnetic resonance spectroscopy | Epidermal growth factor | Pathways | Addiction | Magnetic permeability | Cell lines | Glycolysis | Biomarkers | Lactic acid | Growth factors | Trastuzumab | Cancer | Tumors | Original | Original s
oncogene addiction | breast cancer | HER2 | lactate | glycolysis | ADJUVANT CHEMOTHERAPY | MULTICENTER | PHYSIOLOGY | TRASTUZUMAB | EFFICACY | OPEN-LABEL | HYPOXIA | CELL BIOLOGY | GROWTH | TREATMENT RESPONSE | EXPRESSION | PLUS | Lactates | Breast cancer | DNA microarrays | Analysis | Enrichment | Biotechnology | Nuclear magnetic resonance--NMR | Transcription | Transgenic | Metabolism | Gene expression | Addictions | Ribonucleic acid--RNA | ErbB-2 protein | Magnetic resonance spectroscopy | Epidermal growth factor | Pathways | Addiction | Magnetic permeability | Cell lines | Glycolysis | Biomarkers | Lactic acid | Growth factors | Trastuzumab | Cancer | Tumors | Original | Original s
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2018, Volume 18, Issue 1, pp. 586 - 11
CDCP1, a transmembrane protein with tumor pro-metastatic activity, was recently identified as a prognostic marker in TNBC, the most aggressive breast cancer...
PDGFRβ | ERK1/2 | CDCP1 | IHC | FISH | TNBC | PDGF-BB | Becaplermin - pharmacology | Up-Regulation | Humans | Middle Aged | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Gene Expression Regulation, Neoplastic | Neoplasm Proteins - metabolism | Receptor, Platelet-Derived Growth Factor beta - genetics | Cell Adhesion Molecules - metabolism | Antigens, CD - metabolism | Gene Knockdown Techniques | MAP Kinase Signaling System - drug effects | MAP Kinase Signaling System - genetics | Triple Negative Breast Neoplasms - genetics | Mitogen-Activated Protein Kinase 3 - metabolism | Triple Negative Breast Neoplasms - pathology | Cell Line, Tumor | Female | Mitogen-Activated Protein Kinase 1 - metabolism | RNA, Small Interfering - metabolism | Receptor, Platelet-Derived Growth Factor beta - metabolism
PDGFRβ | ERK1/2 | CDCP1 | IHC | FISH | TNBC | PDGF-BB | Becaplermin - pharmacology | Up-Regulation | Humans | Middle Aged | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Gene Expression Regulation, Neoplastic | Neoplasm Proteins - metabolism | Receptor, Platelet-Derived Growth Factor beta - genetics | Cell Adhesion Molecules - metabolism | Antigens, CD - metabolism | Gene Knockdown Techniques | MAP Kinase Signaling System - drug effects | MAP Kinase Signaling System - genetics | Triple Negative Breast Neoplasms - genetics | Mitogen-Activated Protein Kinase 3 - metabolism | Triple Negative Breast Neoplasms - pathology | Cell Line, Tumor | Female | Mitogen-Activated Protein Kinase 1 - metabolism | RNA, Small Interfering - metabolism | Receptor, Platelet-Derived Growth Factor beta - metabolism
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 11, pp. 1746 - 1752
Purpose The transcription factor forkhead box P3 (FOXP3) up-or downregulates a large number of genes and has been recently reported to be expressed in tumor...
RELAPSE | METASTASIS | ONCOLOGY | LYMPH-NODES | REGULATORY T-CELLS | PANCREAS | PERIPHERAL-BLOOD | RADIOTHERAPY | PREVALENCE | SUPPRESSION | TUMOR MICROENVIRONMENT | Breast Neoplasms - surgery | Forkhead Transcription Factors - biosynthesis | Prognosis | Breast Neoplasms - pathology | Humans | Middle Aged | Survival Analysis | Breast Neoplasms - mortality | Female | Breast Neoplasms - metabolism
RELAPSE | METASTASIS | ONCOLOGY | LYMPH-NODES | REGULATORY T-CELLS | PANCREAS | PERIPHERAL-BLOOD | RADIOTHERAPY | PREVALENCE | SUPPRESSION | TUMOR MICROENVIRONMENT | Breast Neoplasms - surgery | Forkhead Transcription Factors - biosynthesis | Prognosis | Breast Neoplasms - pathology | Humans | Middle Aged | Survival Analysis | Breast Neoplasms - mortality | Female | Breast Neoplasms - metabolism
Journal Article
Cancer Discovery, ISSN 2159-8274, 01/2014, Volume 4, Issue 1, pp. 110 - 129
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 384, pp. 94 - 100
Abstract Exosomes-secreted microRNAs play an important role in metastatic spread. During this process breast cancer cells acquire the ability to transmigrate...
Hematology, Oncology and Palliative Medicine | Breast cancer | Metastasis | miR-939 | Exosomes | Triple-negative breast cancer | CELLS | DIAGNOSIS | ANGIOGENESIS | RISK | MICRORNAS | BIOMARKERS | VESSELS | ONCOLOGY | JUNCTIONS | DISTANT METASTASIS | Exosomes - metabolism | Cadherins - metabolism | Human Umbilical Vein Endothelial Cells - metabolism | Humans | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Antigens, CD - genetics | Antigens, CD - metabolism | Neoplasm Metastasis | Transfection | Time Factors | Transendothelial and Transepithelial Migration | Triple Negative Breast Neoplasms - pathology | Female | Cadherins - genetics | Paracrine Communication | Signal Transduction | Down-Regulation | Proportional Hazards Models | Permeability | Disease-Free Survival | Triple Negative Breast Neoplasms - genetics | Triple Negative Breast Neoplasms - metabolism | Cell Line, Tumor | Human Umbilical Vein Endothelial Cells - pathology | MicroRNAs - genetics | Analysis | Molecular biology | Monomolecular films | Endothelium | Proteins | Cloning | Medical prognosis | Mortality | Conflicts of interest | Binding sites | Methods | Tumors
Hematology, Oncology and Palliative Medicine | Breast cancer | Metastasis | miR-939 | Exosomes | Triple-negative breast cancer | CELLS | DIAGNOSIS | ANGIOGENESIS | RISK | MICRORNAS | BIOMARKERS | VESSELS | ONCOLOGY | JUNCTIONS | DISTANT METASTASIS | Exosomes - metabolism | Cadherins - metabolism | Human Umbilical Vein Endothelial Cells - metabolism | Humans | Gene Expression Regulation, Neoplastic | MicroRNAs - metabolism | Antigens, CD - genetics | Antigens, CD - metabolism | Neoplasm Metastasis | Transfection | Time Factors | Transendothelial and Transepithelial Migration | Triple Negative Breast Neoplasms - pathology | Female | Cadherins - genetics | Paracrine Communication | Signal Transduction | Down-Regulation | Proportional Hazards Models | Permeability | Disease-Free Survival | Triple Negative Breast Neoplasms - genetics | Triple Negative Breast Neoplasms - metabolism | Cell Line, Tumor | Human Umbilical Vein Endothelial Cells - pathology | MicroRNAs - genetics | Analysis | Molecular biology | Monomolecular films | Endothelium | Proteins | Cloning | Medical prognosis | Mortality | Conflicts of interest | Binding sites | Methods | Tumors
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 02/2019, Volume 234, Issue 2, pp. 1768 - 1779
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 01/2013, Volume 228, Issue 1, pp. 30 - 35
FOXP3 is a member of the forkhead/winged‐helix family of transcriptional regulators. Defects in the FOXP3 gene cause an X‐linked autoimmune/immunodeficiency...
BREAST-CANCER | CARCINOMA-CELLS | LUNG-CANCER | ACTIVATION | ONCOGENE | PHYSIOLOGY | INHIBITION | ACETYLATION | REGULATORY T-CELLS | REPRESSOR | ASSOCIATION | CELL BIOLOGY | Neoplasm Metastasis | Animals | Forkhead Transcription Factors - metabolism | T-Lymphocyte Subsets - metabolism | Humans | Forkhead Transcription Factors - genetics | Gene Expression Regulation, Neoplastic - physiology | Development and progression | Metastasis | Genetic transcription | Cancer
BREAST-CANCER | CARCINOMA-CELLS | LUNG-CANCER | ACTIVATION | ONCOGENE | PHYSIOLOGY | INHIBITION | ACETYLATION | REGULATORY T-CELLS | REPRESSOR | ASSOCIATION | CELL BIOLOGY | Neoplasm Metastasis | Animals | Forkhead Transcription Factors - metabolism | T-Lymphocyte Subsets - metabolism | Humans | Forkhead Transcription Factors - genetics | Gene Expression Regulation, Neoplastic - physiology | Development and progression | Metastasis | Genetic transcription | Cancer
Journal Article
Molecular Oncology, ISSN 1574-7891, 02/2016, Volume 10, Issue 2, pp. 253 - 271
Cancer cells within a tumor are functionally heterogeneous and specific subpopulations, defined as cancer initiating cells (CICs), are endowed with higher...
SNAI2 | Microenvironment | CDH1 | Lung cancer | Cancer initiating cells | Plasticity | DOWN-REGULATION | POPULATIONS | E-CADHERIN | MIR-200 FAMILY | TUMOR HETEROGENEITY | FIBROBLASTS | TRANSITION | ZEB1 | ONCOLOGY | EXPRESSION | Cadherins - metabolism | Epigenesis, Genetic | Humans | Lung Neoplasms - metabolism | Transforming Growth Factor beta1 - metabolism | Glycoproteins - metabolism | Lung Neoplasms - pathology | Epithelial-Mesenchymal Transition - genetics | Antigens, CD - metabolism | Peptides - metabolism | Tumor Microenvironment - genetics | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Snail Family Transcription Factors | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | AC133 Antigen | Transcription Factors - metabolism | Phenotype | Animals | Mice, Nude | Cell Line, Tumor | Cell Plasticity | Mice | Primary Cell Culture | Epigenetic inheritance | Analysis | Cancer cells | Stem cells | Transforming growth factors | Tumors | Subpopulations | Phenotypes | Mesenchyme | Laboratories | Breast cancer | Metastasis | Gene expression | E-cadherin | Cell adhesion & migration | Proteins | External stimuli | Medical prognosis | Cell lines | DNA methylation | Fibroblasts | Epigenetics | Snail protein
SNAI2 | Microenvironment | CDH1 | Lung cancer | Cancer initiating cells | Plasticity | DOWN-REGULATION | POPULATIONS | E-CADHERIN | MIR-200 FAMILY | TUMOR HETEROGENEITY | FIBROBLASTS | TRANSITION | ZEB1 | ONCOLOGY | EXPRESSION | Cadherins - metabolism | Epigenesis, Genetic | Humans | Lung Neoplasms - metabolism | Transforming Growth Factor beta1 - metabolism | Glycoproteins - metabolism | Lung Neoplasms - pathology | Epithelial-Mesenchymal Transition - genetics | Antigens, CD - metabolism | Peptides - metabolism | Tumor Microenvironment - genetics | Neoplastic Stem Cells - metabolism | Neoplastic Stem Cells - pathology | Female | Snail Family Transcription Factors | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | AC133 Antigen | Transcription Factors - metabolism | Phenotype | Animals | Mice, Nude | Cell Line, Tumor | Cell Plasticity | Mice | Primary Cell Culture | Epigenetic inheritance | Analysis | Cancer cells | Stem cells | Transforming growth factors | Tumors | Subpopulations | Phenotypes | Mesenchyme | Laboratories | Breast cancer | Metastasis | Gene expression | E-cadherin | Cell adhesion & migration | Proteins | External stimuli | Medical prognosis | Cell lines | DNA methylation | Fibroblasts | Epigenetics | Snail protein
Journal Article
Molecular Oncology, ISSN 1574-7891, 08/2012, Volume 6, Issue 4, pp. 458 - 472
An increasing body of evidence highlights an intriguing interaction between microRNAs and transcriptional factors involved in determining cell fate, including...
E2F1 | LAMC1 | miR-205 | p53 | MiR-205 | P53 | PROSTATE | EXPRESSION ANALYSIS | PROTEIN | LAMININ | DOWN-REGULATION | CELL-PROLIFERATION | SUPPRESSION | INVASION | ONCOLOGY | CARCINOMAS | SENESCENCE | Cell Cycle - genetics | Cellular Senescence - genetics | Cell Proliferation | Humans | Gene Expression Regulation, Neoplastic | Tumor Suppressor Protein p53 - metabolism | Molecular Sequence Data | MicroRNAs - metabolism | E2F1 Transcription Factor - metabolism | Mice, SCID | Down-Regulation - genetics | Xenograft Model Antitumor Assays | Animals | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Base Sequence | Cell Line, Tumor | Protein Binding | Female | Transcription, Genetic | Mice | MicroRNAs - genetics | Response Elements - genetics | Laminin - metabolism | MicroRNA | Emissions (Pollution) | Genomics | Stem cells | Development and progression | Breast cancer | Genetic transcription | Tumor proteins | Cells | Tumors | Cell proliferation | Transcription factors | Transcription | Mesenchyme | p53 Protein | Genomes | Kinases | Experiments | Cell adhesion & migration | Cell fate | Penicillin | Cell adhesion | Cell cycle | Extracellular matrix | Phenotypes | Cloning | MiRNA | Mutagenesis | Plasmids | MicroRNAs | Cell lines | Tumor suppressor genes | Regulation | Mutation | Binding sites | Cell migration | miRNA | p53 protein | Papers | Paper
E2F1 | LAMC1 | miR-205 | p53 | MiR-205 | P53 | PROSTATE | EXPRESSION ANALYSIS | PROTEIN | LAMININ | DOWN-REGULATION | CELL-PROLIFERATION | SUPPRESSION | INVASION | ONCOLOGY | CARCINOMAS | SENESCENCE | Cell Cycle - genetics | Cellular Senescence - genetics | Cell Proliferation | Humans | Gene Expression Regulation, Neoplastic | Tumor Suppressor Protein p53 - metabolism | Molecular Sequence Data | MicroRNAs - metabolism | E2F1 Transcription Factor - metabolism | Mice, SCID | Down-Regulation - genetics | Xenograft Model Antitumor Assays | Animals | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Base Sequence | Cell Line, Tumor | Protein Binding | Female | Transcription, Genetic | Mice | MicroRNAs - genetics | Response Elements - genetics | Laminin - metabolism | MicroRNA | Emissions (Pollution) | Genomics | Stem cells | Development and progression | Breast cancer | Genetic transcription | Tumor proteins | Cells | Tumors | Cell proliferation | Transcription factors | Transcription | Mesenchyme | p53 Protein | Genomes | Kinases | Experiments | Cell adhesion & migration | Cell fate | Penicillin | Cell adhesion | Cell cycle | Extracellular matrix | Phenotypes | Cloning | MiRNA | Mutagenesis | Plasmids | MicroRNAs | Cell lines | Tumor suppressor genes | Regulation | Mutation | Binding sites | Cell migration | miRNA | p53 protein | Papers | Paper
Journal Article
Blood, ISSN 0006-4971, 10/2012, Volume 120, Issue 15, pp. 3007 - 3018
Antineutrophil cytoplasmic antibodies (ANCAs) target proteins normally retained within neutrophils, indicating that cell death is involved in the autoimmunity...
ANTIBODIES | AUTOANTIBODIES | IMMUNITY | SYSTEMIC-LUPUS-ERYTHEMATOSUS | NETTING NEUTROPHILS | DYING CELLS | RECOGNITION | APOPTOTIC NEUTROPHILS | CLINICAL ASSOCIATIONS | VASCULITIS | HEMATOLOGY
ANTIBODIES | AUTOANTIBODIES | IMMUNITY | SYSTEMIC-LUPUS-ERYTHEMATOSUS | NETTING NEUTROPHILS | DYING CELLS | RECOGNITION | APOPTOTIC NEUTROPHILS | CLINICAL ASSOCIATIONS | VASCULITIS | HEMATOLOGY
Journal Article
Molecular Cancer, ISSN 1476-4598, 10/2010, Volume 9, Issue 1, pp. 278 - 278
Background: TPC-1 is a papillary thyroid carcinoma (PTC)-derived cell line that spontaneously expresses the oncogene RET/PTC1. TPC-1 treated with the RET/PTC1...
RET | SURVIVAL | BREAST-CANCER CELLS | ACTIVATION | ONCOLOGY | SIGNALING PATHWAY | MAP KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PAPILLARY THYROID-CARCINOMA | FOCAL ADHESION KINASE | RET/PTC1 ONCOPROTEIN | ANTITUMOR-ACTIVITY | Dasatinib | Proto-Oncogene Proteins c-ret - metabolism | Focal Adhesion Protein-Tyrosine Kinases - metabolism | Humans | Receptor, EphA2 - metabolism | JNK Mitogen-Activated Protein Kinases - metabolism | Pyrimidines - pharmacology | Integrin beta1 - metabolism | Indoles - metabolism | Thyroid Neoplasms - drug therapy | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | p38 Mitogen-Activated Protein Kinases - metabolism | Indoles - antagonists & inhibitors | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | STAT3 Transcription Factor - metabolism | Thyroid Neoplasms - metabolism | Thyroid cancer | Genes | Physiological aspects | Genetic aspects | Research | Drug therapy | Health aspects | Protein kinases | Proteins | Medical research | Enzymes | Phosphorylation | Cell cycle | Clinical medicine | Kinases | Experiments | Manuscripts | Molecular weight | Cancer
RET | SURVIVAL | BREAST-CANCER CELLS | ACTIVATION | ONCOLOGY | SIGNALING PATHWAY | MAP KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PAPILLARY THYROID-CARCINOMA | FOCAL ADHESION KINASE | RET/PTC1 ONCOPROTEIN | ANTITUMOR-ACTIVITY | Dasatinib | Proto-Oncogene Proteins c-ret - metabolism | Focal Adhesion Protein-Tyrosine Kinases - metabolism | Humans | Receptor, EphA2 - metabolism | JNK Mitogen-Activated Protein Kinases - metabolism | Pyrimidines - pharmacology | Integrin beta1 - metabolism | Indoles - metabolism | Thyroid Neoplasms - drug therapy | Cell Line, Tumor | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | p38 Mitogen-Activated Protein Kinases - metabolism | Indoles - antagonists & inhibitors | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | STAT3 Transcription Factor - metabolism | Thyroid Neoplasms - metabolism | Thyroid cancer | Genes | Physiological aspects | Genetic aspects | Research | Drug therapy | Health aspects | Protein kinases | Proteins | Medical research | Enzymes | Phosphorylation | Cell cycle | Clinical medicine | Kinases | Experiments | Manuscripts | Molecular weight | Cancer
Journal Article
12.
Full Text
The PDGFR[beta]/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
BMC Cancer, ISSN 1471-2407, 05/2018, Volume 18, Issue 1
CDCP1, a transmembrane protein with tumor pro-metastatic activity, was recently identified as a prognostic marker in TNBC, the most aggressive breast cancer...
Immunohistochemistry | Breast cancer | Prognosis | Platelet-derived growth factor | Metastasis
Immunohistochemistry | Breast cancer | Prognosis | Platelet-derived growth factor | Metastasis
Journal Article
13.
Full Text
HER2 Overexpression and Doxorubicin in Adjuvant Chemotherapy for Resectable Breast Cancer
Journal of Clinical Oncology, ISSN 0732-183X, 02/2003, Volume 21, Issue 3, pp. 458 - 462
Purpose: Human epidermal growth factor receptor 2 (HER2) overexpression was found to predict a good response in breast carcinoma patients treated with...
WOMEN | ERBB-2 | THERAPY | ONCOLOGY | CYCLOPHOSPHAMIDE | RESIDUALS | METHOTREXATE | TUMOR | REGRESSION-MODEL | FLUOROURACIL | C-ERBB-2 EXPRESSION | Immunohistochemistry | Doxorubicin - therapeutic use | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Receptor, ErbB-2 - biosynthesis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Survival | Breast Neoplasms - genetics | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Adult | Female | Methotrexate - administration & dosage | Aged | Chemotherapy, Adjuvant | Receptor, ErbB-2 - analysis
WOMEN | ERBB-2 | THERAPY | ONCOLOGY | CYCLOPHOSPHAMIDE | RESIDUALS | METHOTREXATE | TUMOR | REGRESSION-MODEL | FLUOROURACIL | C-ERBB-2 EXPRESSION | Immunohistochemistry | Doxorubicin - therapeutic use | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Receptor, ErbB-2 - biosynthesis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Survival | Breast Neoplasms - genetics | Fluorouracil - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Adult | Female | Methotrexate - administration & dosage | Aged | Chemotherapy, Adjuvant | Receptor, ErbB-2 - analysis
Journal Article
CANCER DISCOVERY, ISSN 2159-8274, 01/2014, Volume 4, Issue 1, pp. 110 - 129
Altered expression of matricellular proteins can become pathogenic in the presence of persistent perturbations in tissue homeostasis. Here, we show that...
INFLAMMATORY DISORDERS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | KAPPA-B ACTIVATION | IMMUNE-SYSTEM | DENDRITIC CELLS | ONCOLOGY | MARGINAL ZONE | MATRICELLULAR PROTEIN | GENE-EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | INHIBITORY RECEPTOR LAIR-1 | Autoimmunity | Osteonectin - immunology | Humans | Cells, Cultured | Extracellular Matrix - immunology | Lymphoma - immunology | NF-kappa B - immunology | Neutrophils - immunology | Lymphoma - genetics | Lymphoid Tissue - immunology | Lymphoid Tissue - cytology | Animals | B-Lymphocytes - immunology | Osteonectin - genetics | Mice, Mutant Strains | CD5 Antigens - immunology | fas Receptor - genetics | Mice
INFLAMMATORY DISORDERS | SYSTEMIC-LUPUS-ERYTHEMATOSUS | KAPPA-B ACTIVATION | IMMUNE-SYSTEM | DENDRITIC CELLS | ONCOLOGY | MARGINAL ZONE | MATRICELLULAR PROTEIN | GENE-EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | INHIBITORY RECEPTOR LAIR-1 | Autoimmunity | Osteonectin - immunology | Humans | Cells, Cultured | Extracellular Matrix - immunology | Lymphoma - immunology | NF-kappa B - immunology | Neutrophils - immunology | Lymphoma - genetics | Lymphoid Tissue - immunology | Lymphoid Tissue - cytology | Animals | B-Lymphocytes - immunology | Osteonectin - genetics | Mice, Mutant Strains | CD5 Antigens - immunology | fas Receptor - genetics | Mice
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 10/2019, Volume 9, Issue 1, pp. 1 - 10
Immune and epithelial cells express TLR3, a receptor deputed to respond to microbial signals activating the immune response. The prognostic value ofTLR3 in...
APOPTOSIS | PROGNOSIS | MULTIDISCIPLINARY SCIENCES | TLR3 | Immunohistochemistry | Cell survival | Immune response | Small cell lung carcinoma | PD-1 protein | Tumor cells | Epithelial cells | Stroma | Non-small cell lung carcinoma | Macrophages | Patients | TLR3 protein | Medical prognosis | Surgery | Toll-like receptors
APOPTOSIS | PROGNOSIS | MULTIDISCIPLINARY SCIENCES | TLR3 | Immunohistochemistry | Cell survival | Immune response | Small cell lung carcinoma | PD-1 protein | Tumor cells | Epithelial cells | Stroma | Non-small cell lung carcinoma | Macrophages | Patients | TLR3 protein | Medical prognosis | Surgery | Toll-like receptors
Journal Article